Sansure Biotech Inc Cash Flow Quality Index
Sansure Biotech Inc cash flow quality index. Sansure Biotech Inc (688289) has a Cash Flow Quality Index of 2.09x as of September 2025. Operating cash flow of CN¥59.72 Million exceeds net income of CN¥28.60 Million, indicating high earnings quality where cash backs reported profits. Explore Sansure Biotech Inc (688289) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sansure Biotech Inc (2018–2025)
Cash flow quality index of Sansure Biotech Inc from 2018 to 2025. Historical Cash Flow Quality Index for Sansure Biotech Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. See net asset quality index of Sansure Biotech Inc to measure how much of total assets are equity-financed.
Sansure Biotech Inc Cash Flow Quality Index by Year (2018–2025)
Sansure Biotech Inc cash flow quality index by year from 2018 to 2025. Year-by-year earnings quality comparison for Sansure Biotech Inc. For the full cash flow conversion analysis, see Sansure Biotech Inc cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥183.96 Million | CN¥198.15 Million | ▼ -23.5% |
| 2024 | 1.21x | CN¥274.45 Million | CN¥226.27 Million | ▲ +274.3% |
| 2023 | 0.32x | CN¥112.82 Million | CN¥348.17 Million | ▼ -75.5% |
| 2022 | 1.32x | CN¥2.56 Billion | CN¥1.94 Billion | ▲ +57.9% |
| 2021 | 0.84x | CN¥1.88 Billion | CN¥2.24 Billion | ▼ -17.1% |
| 2020 | 1.01x | CN¥2.64 Billion | CN¥2.62 Billion | ▲ +77.9% |
| 2019 | 0.57x | CN¥22.41 Million | CN¥39.48 Million | ▼ -61.9% |
| 2018 | 1.49x | CN¥10.07 Million | CN¥6.76 Million | — |